Rahme, E <br/><br/>
Therapy switching and associated costs in elderly patients receiving COX-2 selective inhibitors or non-selective non-steroidal anti-inflammatory drugs in Quebec, Canada.  [electronic resource] 

 -  Rheumatology (Oxford, England)  Jul 2006 
 - 903-10 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1462-0324 
<br/><br/><label>Standard No.: </label>10.1093/rheumatology/kei269  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Anti-Inflammatory Agents, Non-Steroidal--economics<br/>Celecoxib<br/>Cyclooxygenase 2 Inhibitors--economics<br/>Drug Costs--statistics & numerical data<br/>Drug Prescriptions--statistics & numerical data<br/>Female<br/>Health Care Costs--statistics & numerical data<br/>Humans<br/>Lactones--administration & dosage<br/>Male<br/>Musculoskeletal Diseases--drug therapy<br/>Pyrazoles--administration & dosage<br/>Quebec<br/>Retrospective Studies<br/>Sulfonamides--administration & dosage<br/>Sulfones--administration & dosage